Treating alzheimer's disease
AssigneesYeda Research and Development Co. Ltd., Ramot at Tel-Aviv University Ltd.
InventorsRuth ARNON, Ruth MARON, Gad ARMONY, Michael Menachem TSOORY, Meir WILCHEK, Dan FRENKEL
Life of this patent
Estimating the term…
Abstract
A method of treating Alzheimer's Disease (AD) is disclosed. The method comprises administering to the subject a therapeutically effective amount of an agent which prevents the binding of amyloid precursor protein (APP) to Tau protein.
Claims9
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and as an active agent at least one peptide which prevents the binding of amyloid precursor protein (APP) to Tau protein, wherein said at least one peptide comprises the amino acid sequence as set forth in SEQ ID NO:
- 1 and SEQ ID NO:
- 3.
Dependencies are inferred from the claim text.